Education
About Us
Working with TipRanks
Follow Us
Aaron Ondrey Insider Profile
4 Followers
Aaron Ondrey, CFO at Mirati Therapeutics, holds 137.14K shares in Rocket Pharmaceuticals (Ticker: RCKT), holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX).
Aaron Ondrey Mirati Therapeutics (MRTX)CFO
Mirati Therapeutics (MRTX)
CFO
Not Ranked
Aaron Ondrey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CFO
Roles that Aaron Ondrey holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Aaron Ondrey
Aaron Ondrey's Trading History
Mirati Therapeutics
Jan 23, 2024
―
Uninformative Sell
―
$0.00
Rocket Pharmaceuticals
Feb 13, 2025
CFO
Uninformative Buy
―
$1.20M
List of latest transactions for each holding click on a transaction to see Aaron Ondrey's performance on stock
You May Also Like
Aaron Ondrey insider profile FAQ
What is the percentage of profitable transactions made by Aaron Ondrey?
The percentage of profitable transactions made by Aaron Ondrey is ―.
What is the average return per transaction made by Aaron Ondrey?
The average return per transaction made by Aaron Ondrey is ―.
What stocks does Aaron Ondrey hold?
Aaron Ondrey holds: MRTX, RCKT stocks.
What was Aaron Ondrey’s latest transaction?
Aaron Ondrey latest transaction was an Uninformative Buy of ―.
What was Aaron Ondrey's most profitable transaction?
Aaron Ondrey’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Aaron Ondrey's role in Mirati Therapeutics?
Aaron Ondrey's role in Mirati Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.